Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03031340 · ClinicalTrials.gov registry record · Phase 3
Evaluating the Role of Pregabalin in Reducing Opioid Requirement in Spinal Fusion Surgeries of Two or More Vertebrae
A Phase 3 study, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 3
- Enrollment target
NCT03031340 is a Phase 3 study that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 3 participants.
The verdict
NCT03031340, a Phase 3 study, was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 3 participants
- Enrollment target
Study Summary
To see if the administration of 3 dosses of pregabalin (1 dose preoperative, 2 doses postoperative) will reduce the postoperative opiate requirements of patients undergoing spinal fusion surgeries of two or more vertebrae.
Interventions
- OTHER placebo
- DRUG Pregabalin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2012-05 |
| Est. Completion | 2012-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03031340
The ClinicalTrials.gov registry entry for NCT03031340 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT03031340 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03031340 about?
NCT03031340 is a clinical study titled "Evaluating the Role of Pregabalin in Reducing Opioid Requirement in Spinal Fusion Surgeries of Two or More Vertebrae". To see if the administration of 3 dosses of pregabalin (1 dose preoperative, 2 doses postoperative) will reduce the postoperative opiate requirements of patients undergoing spinal fusion surgeries of two or more vertebrae.
What is the current status of trial NCT03031340?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 3 participants. The study started on 2012-05. Estimated completion is 2012-09.
What interventions are being tested in trial NCT03031340?
The interventions under investigation include: placebo (OTHER), Pregabalin (DRUG).
Who is sponsoring clinical trial NCT03031340?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.